{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:06:01Z","timestamp":1784113561542,"version":"3.55.0"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cellsig.2020.109903","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T10:19:27Z","timestamp":1608891567000},"page":"109903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["RAS inhibition in resident fibroblast biology"],"prefix":"10.1016","volume":"80","author":[{"given":"Alexandra M.","family":"Garvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal S.","family":"Khokhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Czubryt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taben M.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.RES.82.1.13","article-title":"Local angiotensin II generation in the rat heart","volume":"82","author":"M\u00fcller","year":"1998","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0010","first-page":"R849","article-title":"Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy","volume":"274","author":"Heller","year":"1998","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"3 Pt 2","key":"10.1016\/j.cellsig.2020.109903_bb0015","first-page":"H1040","article-title":"Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction","volume":"271","author":"Passier","year":"1996","journal-title":"Am. J. Phys."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0020","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1006\/jmcc.2001.1365","article-title":"Renin expression at sites of repair in the infarcted rat heart","volume":"33","author":"Sun","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.RES.68.1.141","article-title":"Localization of angiotensin converting enzyme in rat heart","volume":"68","author":"Yamada","year":"1991","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0030","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI114924","article-title":"Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation","volume":"86","author":"Schunkert","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0035","first-page":"H1268","article-title":"Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction","volume":"269","author":"Passier","year":"1995","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.HYP.30.1.42","article-title":"Angiotensin II Type 1 (AT1) receptor\u2013mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo","volume":"30","author":"van Kats","year":"1997","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.98.1.73","article-title":"Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions","volume":"98","author":"van Kats","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/boc.201400015","article-title":"Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts","volume":"106","author":"Tao","year":"2014","journal-title":"Biol. Cell."},{"issue":"4 Pt 2","key":"10.1016\/j.cellsig.2020.109903_bb0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/01.HYP.25.4.796","article-title":"Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension","volume":"25","author":"Nakamoto","year":"1995","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0060","doi-asserted-by":"crossref","first-page":"H1328","DOI":"10.1152\/ajpheart.00538.2010","article-title":"Local angiotensin II aggravates cardiac remodeling in hypertension","volume":"299","author":"Xu","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cellsig.2020.109903_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91-92","author":"AlQudah","year":"2020","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/hr.2015.107","article-title":"Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition","volume":"39","author":"Biwer","year":"2016","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.0000129539.88028.e6","article-title":"Persistent lowering of pressure by transplanting kidneys from adult spontaneously hypertensive rats treated with brief antihypertensive therapy","volume":"44","author":"Smallegange","year":"2004","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0080","doi-asserted-by":"crossref","first-page":"H1675","DOI":"10.1152\/ajpheart.91493.2007","article-title":"Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production","volume":"294","author":"Singh","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109903_bb0085","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/cvr\/28.9.1423","article-title":"Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat","volume":"28","author":"Sun","year":"1994","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0090","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmcc.1997.0376","article-title":"Cultured myofibroblasts generate angiotensin peptides de novo","volume":"29","author":"Katwa","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0008-6363(95)00232-4","article-title":"Cells expressing angiotensin II receptors in fibrous tissue of rat heart","volume":"31","author":"Sun","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cellsig.2020.109903_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2016.05.010","article-title":"Molecular mechanisms in H2O2-induced increase in AT1 receptor gene expression in cardiac fibroblasts: a role for endogenously generated Angiotensin II","volume":"97","author":"Anupama","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004965","article-title":"Intracellular angiotensin-II interacts with nuclear angiotensin receptors in cardiac fibroblasts and regulates rna synthesis, cell proliferation, and collagen secretion","volume":"6","author":"Tadevosyan","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0110","doi-asserted-by":"crossref","first-page":"C1457","DOI":"10.1152\/ajpcell.2001.281.5.C1457","article-title":"Upregulation of alpha(8)beta(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta1","volume":"281","author":"Thibault","year":"2001","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"1\u20133","key":"10.1016\/j.cellsig.2020.109903_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.regpep.2003.07.003","article-title":"Fibrosis rather than blood pressure determines cardiac BNP expression in mice","volume":"116","author":"Walther","year":"2003","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.cellsig.2020.109903_bb0125","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/01.CIR.100.20.2093","article-title":"Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction","volume":"100","author":"Harada","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0130","doi-asserted-by":"crossref","first-page":"H1004","DOI":"10.1152\/ajpheart.00886.2005","article-title":"Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling","volume":"290","author":"Voros","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cellsig.2020.109903_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yjmcc.2019.11.152","article-title":"Cellular cross-talks in the diseased and aging heart","volume":"138","author":"Wagner","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109903_bb0140","first-page":"H1385","article-title":"Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences","volume":"303","author":"Zhang","year":"2012","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0145","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/physrev.00008.2011","article-title":"Matricellular proteins in cardiac adaptation and disease","volume":"92","author":"Frangogiannis","year":"2012","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.RES.74.4.727","article-title":"Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat","volume":"74","author":"Crawford","year":"1994","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0165","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/HYPERTENSIONAHA.109.140608","article-title":"C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease","volume":"55","author":"Zhang","year":"2010","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.yjmcc.2010.05.005","article-title":"Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy","volume":"49","author":"Haudek","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109903_bb0175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb0180","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ajh\/hpt095","article-title":"Role for granulocyte colony stimulating factor in angiotensin II-induced neutrophil recruitment and cardiac fibrosis in mice","volume":"26","author":"Jiang","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cellsig.2020.109903_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lfs.2016.04.013","article-title":"Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis","volume":"153","author":"Bai","year":"2016","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0190","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1006\/jmcc.1996.0080","article-title":"Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart","volume":"28","author":"Sun","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0195","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1006\/jmcc.1998.0721","article-title":"Angiotensin II, Transforming Growth Factor-\u03b21and Repair in the Infarcted Heart","volume":"30","author":"Sun","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0200","doi-asserted-by":"crossref","DOI":"10.1177\/1470320318759358","article-title":"Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-\u03b2 signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis","volume":"19","author":"Wong","year":"2018","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cvr\/cvr067","article-title":"Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-\u03b21 pathways in cardiac fibroblasts","volume":"91","author":"Li","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109903_bb0210","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1006\/jmcc.1997.0435","article-title":"Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts","volume":"29","author":"Campbell","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb0215","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0022-2828(95)91983-X","article-title":"Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts","volume":"27","author":"Lee","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0220","doi-asserted-by":"crossref","first-page":"H3020","DOI":"10.1152\/ajpheart.2000.279.6.H3020","article-title":"Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro","volume":"279","author":"Hao","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109903_bb0225","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1006\/jmcc.1997.0489","article-title":"The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes","volume":"29","author":"McWhinney","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0230","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/HYPERTENSIONAHA.118.11860","article-title":"Angiotensin II causes biphasic STAT3 activation through TLR4 to initiate cardiac remodeling","volume":"72","author":"Han","year":"2018","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"key":"10.1016\/j.cellsig.2020.109903_bb0235","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49923","article-title":"Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis","volume":"9","author":"Bao","year":"2020","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0240","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0245","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.117.311045","article-title":"EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-\u03b2\/Smad3 signaling","volume":"121","author":"Su","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00395-019-0721-6","article-title":"The different response of cardiomyocytes and cardiac fibroblasts to mitochondria inhibition and the underlying role of STAT3","volume":"114","author":"Zhao","year":"2019","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cellsig.2020.109903_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yjmcc.2018.08.017","article-title":"Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice","volume":"123","author":"Reddy","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.21010\/ajtcam.v14i1.16","article-title":"Effect of triptolide on proliferation and apoptosis of angiotensin II-induced cardiac fibroblasts in vitro: a preliminary study","volume":"14","author":"Liu","year":"2017","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0265","first-page":"474","article-title":"Curcumin suppress cardiac fibroblasts activities by regulating proliferation, migration, and the extracellular matrix","volume":"30","author":"Chung","year":"2014","journal-title":"Acta Cardiol. Sin."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098483","article-title":"Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF \u03b2-Smad signal pathway","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0275","doi-asserted-by":"crossref","first-page":"H2952","DOI":"10.1152\/ajpheart.00004.2007","article-title":"Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat","volume":"293","author":"Xu","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109903_bb0280","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1210\/en.2004-0209","article-title":"Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo","volume":"145","author":"Samuel","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.117.10094","article-title":"MicroRNA-221\/222 family counteracts myocardial fibrosis in pressure overload-induced heart failure","volume":"71","author":"Verjans","year":"2018","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"key":"10.1016\/j.cellsig.2020.109903_bb0290","doi-asserted-by":"crossref","first-page":"172549","DOI":"10.1016\/j.ejphar.2019.172549","article-title":"Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-\u03b21 signaling pathway","volume":"859","author":"Ding","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0295","first-page":"2070","article-title":"MiRNA-1297 inhibits myocardial fibrosis by targeting ULK1","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2020.109903_bb0300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fcvm.2019.00065","article-title":"MicroRNA-1-mediated inhibition of cardiac fibroblast proliferation through targeting cyclin D2 and CDK6","volume":"6","author":"Valkov","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13577-020-00326-w","article-title":"Downregulation of miR-96 suppresses the profibrogenic functions of cardiac fibroblasts induced by angiotensin II and attenuates atrial fibrosis by upregulating KLF13","volume":"33","author":"Su","year":"2020","journal-title":"Hum. Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0310","doi-asserted-by":"crossref","first-page":"H239","DOI":"10.1152\/ajpheart.00584.2015","article-title":"TGF\u03b21 regulates Scleraxis expression in primary cardiac myofibroblasts by a Smad-independent mechanism","volume":"310","author":"Zeglinski","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb0315","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.bbamcr.2012.07.002","article-title":"Synergistic roles of scleraxis and Smads in the regulation of collagen 1\u03b12 gene expression","volume":"1823","author":"Bagchi","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2020.109903_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12915-016-0243-8","article-title":"The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype","volume":"14","author":"Bagchi","year":"2016","journal-title":"BMC Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00441-016-2439-1","article-title":"Regulation of fibronectin gene expression in cardiac fibroblasts by scleraxis","volume":"366","author":"Bagchi","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cellsig.2020.109903_bb0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2018.05.004","article-title":"Regulation of cardiac fibroblast MMP2 gene expression by scleraxis","volume":"120","author":"Nagalingam","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0335","doi-asserted-by":"crossref","first-page":"C297","DOI":"10.1152\/ajpcell.00333.2015","article-title":"Role of scleraxis in mechanical stretch-mediated regulation of cardiac myofibroblast phenotype","volume":"311","author":"Roche","year":"2016","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"suppl_1","key":"10.1016\/j.cellsig.2020.109903_bb0340","doi-asserted-by":"crossref","first-page":"A192","DOI":"10.1161\/res.115.suppl_1.192","article-title":"Abstract 192: scleraxis is a required component of the cardiac extracellular matrix gene expression program","volume":"115","author":"Czubryt","year":"2014","journal-title":"Circ. Res."},{"issue":"S1","key":"10.1016\/j.cellsig.2020.109903_bb0345","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.25.1_supplement.1032.9","article-title":"Angiotensin II up-regulates the expression of scleraxis in cardiac myofibroblasts isolated from the site of myocardial infarction","volume":"25","author":"Salameh","year":"2011","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109903_bb0350","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.116.308643","article-title":"Targeted ablation of periostin-expressing activated fibroblasts prevents adverse cardiac remodeling in mice","volume":"118","author":"Kaur","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0355","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/HYPERTENSIONAHA.106.080994","article-title":"Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin","volume":"49","author":"Iekushi","year":"2007","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0365","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.107.149047","article-title":"Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling","volume":"101","author":"Oka","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.cellsig.2020.109903_bb0370","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2018.07.130","article-title":"CTGF\/CCN2 is an autocrine regulator of cardiac fibrosis","volume":"121","author":"Dorn","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"13","key":"10.1016\/j.cellsig.2020.109903_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93187","article-title":"Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction","volume":"2","author":"Shimizu","year":"2017","journal-title":"JCI Insight"},{"issue":"32","key":"10.1016\/j.cellsig.2020.109903_bb0380","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/eurheartj\/ehv109","article-title":"Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis","volume":"36","author":"Lorenzen","year":"2015","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109903_bb0385","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jacc.2003.11.058","article-title":"Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart","volume":"43","author":"Collins","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0390","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00395-014-0428-7","article-title":"Cardiac fibroblasts support cardiac inflammation in heart failure","volume":"109","author":"Lindner","year":"2014","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0395","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajpath.2014.11.027","article-title":"Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis","volume":"185","author":"Falkenham","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035144","article-title":"Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by angiotensin II","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0405","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/jcmm.12512","article-title":"Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6","volume":"19","author":"Zhou","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellsig.2020.109903_bb0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2013.01.006","article-title":"TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis","volume":"57","author":"Duerrschmid","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109903_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138372","article-title":"Tumor necrosis factor - alpha is essential for angiotensin II-induced ventricular remodeling: role for oxidative stress","volume":"10","author":"Sriramula","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0420","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cvr\/cvt258","article-title":"Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation","volume":"101","author":"Wang","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2020.109903_bb0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","article-title":"Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats","volume":"317","author":"Zhao","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb0430","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1177\/1535370214561958","article-title":"Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation","volume":"240","author":"Zhang","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"7","key":"10.1016\/j.cellsig.2020.109903_bb0435","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NF\u03baB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cellsig.2020.109903_bb0440","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.febslet.2005.03.057","article-title":"H2O2 activates Nox4 through PLA2-dependent arachidonic acid production in adult cardiac fibroblasts","volume":"579","author":"Colston","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0445","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.acvd.2017.03.011","article-title":"Nox4 genetic inhibition in experimental hypertension and metabolic syndrome","volume":"111","author":"Bouabout","year":"2018","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0450","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jcp.25210","article-title":"The Nox1\/4 dual inhibitor GKT137831 or Nox4 knockdown inhibits angiotensin-II-induced adult mouse cardiac fibroblast proliferation and migration. AT1 physically associates with Nox4","volume":"231","author":"Somanna","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2020.109903_bb0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.09.015","article-title":"Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK","volume":"65","author":"Siddesha","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cellsig.2020.109903_bb0460","doi-asserted-by":"crossref","first-page":"691070","DOI":"10.1155\/2015\/691070","article-title":"Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis","volume":"2015","author":"Meng","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0465","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1016\/j.ijcard.2013.06.007","article-title":"Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response","volume":"168","author":"Pan","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0470","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1152\/physiolgenomics.00057.2004","article-title":"Cardiac transcriptional response to acute and chronic angiotensin II treatments","volume":"18","author":"Larkin","year":"2004","journal-title":"Physiol. Genomics"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0475","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbrc.2015.06.101","article-title":"Cytoplasmic translocation of HuR contributes to angiotensin II induced cardiac fibrosis","volume":"463","author":"Bai","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0480","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.anes.0000365960.74268.21","article-title":"Propofol depresses angiotensin II-induced cell proliferation in rat cardiac fibroblasts","volume":"112","author":"Cheng","year":"2010","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.cellsig.2020.109903_bb0485","article-title":"The association of ascorbic acid, deferoxamine and N-acetylcysteine improves cardiac fibroblast viability and cellular function associated with tissue repair damaged by simulated ischemia\/reperfusion","volume":"8","author":"Parra-Flores","year":"2019","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0490","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yexcr.2019.03.006","article-title":"Unique mechanistic insights into the beneficial effects of angiotensin-(1-7) on the prevention of cardiac fibrosis: a metabolomic analysis of primary cardiac fibroblasts","volume":"378","author":"Chen","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"33","key":"10.1016\/j.cellsig.2020.109903_bb0495","doi-asserted-by":"crossref","first-page":"34882","DOI":"10.1074\/jbc.M404616200","article-title":"Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death","volume":"279","author":"Mayorga","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0500","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/iub.1967","article-title":"Angiotensin II confers resistance to apoptosis in cardiac myofibroblasts through the AT1\/ERK1\/2\/RSK1 pathway","volume":"71","author":"Cai","year":"2019","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216218","article-title":"Epigenetic control of the angiotensin-converting enzyme in endothelial cells during inflammation","volume":"14","author":"Mudersbach","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0510","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000258855.60637.58","article-title":"Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension","volume":"100","author":"Bogdarina","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0515","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40139-018-0155-0","article-title":"Epigenetic regulation of myofibroblast phenotypes in fibrosis","volume":"6","author":"Duong","year":"2018","journal-title":"Curr. Pathobiol. Rep."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb0520","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/hr.2016.54","article-title":"Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation","volume":"39","author":"Somanna","year":"2016","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0525","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2011.04.005","article-title":"Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension","volume":"51","author":"Lemon","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cellsig.2020.109903_bb0535","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","article-title":"Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes","volume":"67","author":"Williams","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cellsig.2020.109903_bb0540","doi-asserted-by":"crossref","first-page":"2634976","DOI":"10.1155\/2016\/2634976","article-title":"Role of histone demethylases in cardiomyocytes induced to hypertrophy","volume":"2016","author":"Rosales","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0545","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.111.182428","article-title":"Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications","volume":"59","author":"Lee","year":"2012","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0550","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-017-00840-w","article-title":"Loss of \u03b2-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice","volume":"8","author":"Xiang","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0555","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbrc.2020.05.115","article-title":"Targeting JMJD3 histone demethylase mediates cardiac fibrosis and cardiac function following myocardial infarction","volume":"528","author":"Long","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0560","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/s41467-019-12103-x","article-title":"Mitochondrial calcium exchange links metabolism with the epigenome to control cellular differentiation","volume":"10","author":"Lombardi","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0565","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1002\/jcp.27471","article-title":"DNA methylation regulates \u03b1-smooth muscle actin expression during cardiac fibroblast differentiation","volume":"234","author":"He","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0570","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000458520","article-title":"Hypomethylation of the angiotensin II type I receptor (AGTR1) gene along with environmental factors increases the risk for essential hypertension","volume":"137","author":"Lin","year":"2017","journal-title":"Cardiology"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008564","article-title":"Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure","volume":"5","author":"Movassagh","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0580","first-page":"704","article-title":"Epigenetics in cardiac fibrosis","volume":"3","author":"Felisbino","year":"2018","journal-title":"JACC"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0585","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/j.2040-4603.2018.tb00023.x","article-title":"Epigenetics of aberrant cardiac wound healing","volume":"8","author":"Russell-Hallinan","year":"2018","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0590","first-page":"1954","article-title":"An RNA-sequencing study identifies candidate genes for angiotensin II-induced cardiac remodeling","volume":"17","author":"Shu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2020.109903_bb0595","unstructured":"McLellan MA, Skelly DA, Dona MSI, Squiers GT, Farrugia GE, Gaynor TL, Cohen CD, Pandey R, Diep H, Vinh A, Rosenthal NA, Pinto AR. High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy. Circulation.0(0)."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0600","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/apha.12829","article-title":"Targeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation","volume":"220","author":"Oosterhuis","year":"2017","journal-title":"Acta Physiol. (Oxford, England)"},{"issue":"52","key":"10.1016\/j.cellsig.2020.109903_bb0605","doi-asserted-by":"crossref","first-page":"e12245","DOI":"10.1073\/pnas.1805829115","article-title":"Profiling proliferative cells and their progeny in damaged murine hearts","volume":"115","author":"Kretzschmar","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109903_bb0610","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.celrep.2020.02.008","article-title":"Dynamic interstitial cell response during myocardial infarction predicts resilience to rupture in genetically diverse mice","volume":"30","author":"Forte","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0615","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.117.030742","article-title":"Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation","volume":"138","author":"Gladka","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cellsig.2020.109903_bb0620","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0625","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.bjp.0703544","article-title":"Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism","volume":"131","author":"Weidenbach","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109903_bb0630","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.amjhyper.2007.02.004","article-title":"Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats","volume":"20","author":"Ito","year":"2007","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0635","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/jmcc.1999.1053","article-title":"Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis","volume":"32","author":"Katoh","year":"2000","journal-title":"J. Mol. Cell Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0640","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.bjp.0707472","article-title":"Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats","volume":"152","author":"Liang","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.cellsig.2020.109903_bb0645","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.104.528695","article-title":"Angiotensin-converting enzyme inhibitors: a new mechanism of action","volume":"112","author":"Peng","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0650","doi-asserted-by":"crossref","first-page":"H310","DOI":"10.1152\/ajpheart.01137.2009","article-title":"Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model","volume":"299","author":"Stein","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0655","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0008-6363(99)00432-0","article-title":"Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs","volume":"46","author":"Brilla","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0660","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00004872-199917080-00022","article-title":"Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats","volume":"17","author":"Susic","year":"1999","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109903_bb0665","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.110.227454","article-title":"Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction","volume":"107","author":"Leuschner","year":"2010","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109903_bb0670","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1097\/HJH.0b013e3282ef84f8","article-title":"Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage","volume":"25","author":"Baumann","year":"2007","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0675","first-page":"207","article-title":"Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age","volume":"25","author":"Baumann","year":"2007","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0680","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3892\/ijmm.2012.1153","article-title":"Transient prehypertensive treatment in spontaneously hypertensive rats: A comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection","volume":"30","author":"Peng","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0685","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005344-199308000-00021","article-title":"Losartan\u2019s protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal","volume":"22","author":"Fornes","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0690","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1073\/pnas.93.1.156","article-title":"Angiotensin II type 2 receptor mediates programmed cell death","volume":"93","author":"Yamada","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.cellsig.2020.109903_bb0695","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2009.12.009","article-title":"ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis","volume":"629","author":"Guo","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0700","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/FJC.0b013e3181a98b31","article-title":"Synergistic attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesartan","volume":"54","author":"Meng","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0705","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/PL00005366","article-title":"Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts","volume":"359","author":"van Eickels","year":"1999","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0710","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.yjmcc.2003.12.004","article-title":"Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats","volume":"36","author":"Ahmed","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0715","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00004872-200403000-00023","article-title":"Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension","volume":"22","author":"Rasoul","year":"2004","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0720","doi-asserted-by":"crossref","first-page":"H1357","DOI":"10.1152\/ajpheart.00464.2009","article-title":"Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts","volume":"298","author":"Peng","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0725","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.0000025880.56816.FA","article-title":"N-acetyl-Ser-Asp-Lys-Pro inhibits phosphorylation of Smad2 in cardiac fibroblasts","volume":"40","author":"Pokharel","year":"2002","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"suppl N","key":"10.1016\/j.cellsig.2020.109903_bb0730","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/16.suppl_N.12","article-title":"Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides","volume":"16","author":"Weber","year":"1995","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109903_bb0735","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and neprilysin inhibition","volume":"133","author":"Hubers","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0740","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","article-title":"Sacubitril\/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0745","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1013723922582","article-title":"Apoptosis in cardiovascular remodeling\u2014effect of medication","volume":"15","author":"deBlois","year":"2001","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0750","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0008-6363(02)00789-7","article-title":"deBlois D. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril","volume":"57","author":"Der Sarkissian","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0755","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1139\/y05-001","article-title":"Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage","volume":"83","author":"deBlois","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0760","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jash.2013.01.002","article-title":"Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats","volume":"7","author":"Der Sarkissian","year":"2013","journal-title":"J. Am. Soc. Hypertens."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0765","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/HJH.0b013e3280e126d5","article-title":"Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine","volume":"25","author":"Duguay","year":"2007","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0770","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.HYP.34.2.229","article-title":"Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity","volume":"34","author":"Tea","year":"1999","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0775","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jjcc.2008.07.018","article-title":"Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-beta inhibition and apoptosis induction in spontaneously hypertensive rats","volume":"52","author":"Akashiba","year":"2008","journal-title":"J. Cardiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0780","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1254\/jphs.93.163","article-title":"Protective effect of benidipine against sodium azide-induced cell death in cultured neonatal rat cardiac myocytes","volume":"93","author":"Inomata","year":"2003","journal-title":"J. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0785","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1046\/j.1523-1755.2003.00927.x","article-title":"Cardiomyocyte loss in experimental renal failure: prevention by ramipril","volume":"63","author":"Amann","year":"2003","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0790","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0008-6363(02)00721-6","article-title":"Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction","volume":"57","author":"Backlund","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cellsig.2020.109903_bb0795","doi-asserted-by":"crossref","first-page":"3182764","DOI":"10.1155\/2016\/3182764","article-title":"Amlodipine ameliorates ischemia-induced neovascularization in diabetic rats through endothelial progenitor cell mobilization","volume":"2016","author":"Sun","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0800","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.fjc.0000175234.95831.3e","article-title":"Perindopril regulates beta-agonist-induced cardiac apoptosis","volume":"46","author":"Galvez","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0805","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11589400-000000000-00000","article-title":"ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes","volume":"11","author":"Cangiano","year":"2011","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.cellsig.2020.109903_bb0810","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.phrs.2013.08.003","article-title":"The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis","volume":"76","author":"Monti","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0815","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjcard.2009.08.648","article-title":"Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules","volume":"105","author":"Deftereos","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0820","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/joic.12153","article-title":"Effect of Angiotensin converting enzyme inhibitors on soluble tumor-necrosis-factor-related apoptosis-inducing ligand levels - association with neointimal hyperplasia in drug eluting stents","volume":"27","author":"Giannopoulos","year":"2014","journal-title":"J. Interv. Cardiol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0825","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000071188","article-title":"Angiotensin-converting enzyme inhibition induces death receptor apoptotic pathways in erythroid precursors following renal transplantation","volume":"23","author":"Glezerman","year":"2003","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0830","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.leukres.2008.09.029","article-title":"Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents","volume":"33","author":"De la Iglesia","year":"2009","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0835","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjp.0707334","article-title":"Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine","volume":"151","author":"Duguay","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0840","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.bjp.0705642","article-title":"deBlois D. Kinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor","volume":"141","author":"Duguay","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0845","article-title":"Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS\/P38MAPK\/TGF-\u03b21 signaling pathway","volume":"17","author":"Min","year":"2012","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0850","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1748-1716.2012.02474.x","article-title":"Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment","volume":"207","author":"Biwer","year":"2013","journal-title":"Acta Physiol. (Oxford, England)"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0855","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/HJH.0b013e32833fb7cb","article-title":"Changes critical to persistent lowering of arterial pressure in spontaneously hypertensive rat occur early in antihypertensive treatment","volume":"29","author":"Hale","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cellsig.2020.109903_bb0860","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/01.HYP.0000079309.68998.65","article-title":"Time course of vascular structural changes during and after short-term antihypertensive treatment","volume":"42","author":"Hale","year":"2003","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0865","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1681.1994.tb02479.x","article-title":"Blood pressure and lifespan following brief ACE inhibitor treatment in young spontaneously hypertensive rats","volume":"21","author":"Harrap","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0870","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.HYP.16.6.603","article-title":"Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term","volume":"16","author":"Harrap","year":"1990","journal-title":"Hypertension (Dallas, Tex\u202f: 1979)"},{"key":"10.1016\/j.cellsig.2020.109903_bb0875","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2015.11.027","article-title":"Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition","volume":"93","author":"Hale","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0880","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/hr.2012.2","article-title":"Short-term ACE inhibition confers long-term protection against target organ damage","volume":"35","author":"Hale","year":"2012","journal-title":"Hypertens. Res."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0885","doi-asserted-by":"crossref","first-page":"H1346","DOI":"10.1152\/ajpheart.00615.2015","article-title":"Persistent change in cardiac fibroblast physiology after transient ACE inhibition","volume":"309","author":"D\u2019Souza","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0890","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.RES.69.2.475","article-title":"Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure","volume":"69","author":"Hirsch","year":"1991","journal-title":"Circ. Res."},{"issue":"3 Pt 2","key":"10.1016\/j.cellsig.2020.109903_bb0895","first-page":"H760","article-title":"ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure","volume":"264","author":"Reiss","year":"1993","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0900","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI117675","article-title":"Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction","volume":"95","author":"Nio","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109903_bb0905","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1006\/jmcc.1993.1149","article-title":"Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats","volume":"25","author":"Yamagishi","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0910","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.89.5.2273","article-title":"Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat","volume":"89","author":"Schieffer","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0915","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.CIR.72.2.406","article-title":"Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril","volume":"72","author":"Pfeffer","year":"1985","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb0920","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1369\/jhc.4A6560.2005","article-title":"Connective tissue growth factor and cardiac fibrosis after myocardial infarction","volume":"53","author":"Dean","year":"2005","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0925","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.carpath.2016.01.004","article-title":"Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction","volume":"25","author":"Gonzalez","year":"2016","journal-title":"Cardiovasc. Pathol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0930","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1113\/EP085108","article-title":"Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction","volume":"100","author":"Inthachai","year":"2015","journal-title":"Exp. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109903_bb0935","article-title":"Renin-angiotensin-aldosterone signaling inhibitors-losartan, enalapril, and cardosten-prevent infarction-induced heart failure development in rats","volume":"22","author":"Kiss","year":"2016","journal-title":"Alt. Therap. Health Med."},{"issue":"19","key":"10.1016\/j.cellsig.2020.109903_bb0940","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/01.CIR.98.19.2074","article-title":"Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat\u202f: effects of ramipril and hydralazine","volume":"98","author":"Nguyen","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb0945","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00229743","article-title":"Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction","volume":"165","author":"Dixon","year":"1996","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2020.109903_bb0950","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jnutbio.2015.09.025","article-title":"Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats","volume":"28","author":"Raj","year":"2016","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109903_bb0955","first-page":"3410","article-title":"Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction","volume":"8","author":"Qu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0960","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00395-014-0421-1","article-title":"Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition","volume":"109","author":"Fraccarollo","year":"2014","journal-title":"Basic Res. Cardiol."},{"issue":"20","key":"10.1016\/j.cellsig.2020.109903_bb0965","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0970","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-2143(97)90077-9","article-title":"Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart","volume":"129","author":"De Carvalho","year":"1997","journal-title":"J. Lab. Clin. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109903_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135778","article-title":"Evaluation of left ventricle function by regional fractional area change (RFAC) in a mouse model of myocardial infarction secondary to valsartan treatment","volume":"10","author":"Castiglioni","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.cellsig.2020.109903_bb0980","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1111\/bph.12736","article-title":"Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53","volume":"171","author":"Chen","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb0985","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/labinvest.2011.45","article-title":"Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma","volume":"91","author":"Maejima","year":"2011","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109903_bb0990","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00005344-199805000-00002","article-title":"Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats","volume":"31","author":"Taylor","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb0995","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0735-1097(01)01518-2","article-title":"Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction","volume":"38","author":"Yu","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb1000","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.cellsig.2020.109903_bb1005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.01.077","article-title":"Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction","volume":"258","author":"Kompa","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109903_bb1010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1139\/cjpp-2019-0078","article-title":"Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?","volume":"97","author":"Badae","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109903_bb1015","doi-asserted-by":"crossref","first-page":"103486","DOI":"10.1016\/j.jprot.2019.103486","article-title":"Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4","volume":"208","author":"G\u00f3mez-Mendoza","year":"2019","journal-title":"J. Proteome"},{"issue":"6","key":"10.1016\/j.cellsig.2020.109903_bb1020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9343(03)00435-2","article-title":"Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction","volume":"115","author":"Rodrigues","year":"2003","journal-title":"Am. J. Med."},{"issue":"9215","key":"10.1016\/j.cellsig.2020.109903_bb1025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb1030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/18.1.41","article-title":"Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators","volume":"18","author":"Cleland","year":"1997","journal-title":"Eur. Heart J."},{"issue":"9064","key":"10.1016\/j.cellsig.2020.109903_bb1035","first-page":"1493","article-title":"Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE extension (AIREX) study","volume":"349","author":"Hall","year":"1997","journal-title":"Acute Infarction Ramipril Efficacy. Lancet."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109903_bb1040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"9335","key":"10.1016\/j.cellsig.2020.109903_bb1045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal trial in myocardial infarction with angiotensin II antagonist losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109903_bb1050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","article-title":"The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)","volume":"47","author":"McMurray","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109903_bb1055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","article-title":"Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease","volume":"10","author":"Kessler","year":"2019","journal-title":"Biol. Sex Differ."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820303806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820303806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:58:19Z","timestamp":1760266699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820303806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":211,"alternative-id":["S0898656820303806"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109903","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS inhibition in resident fibroblast biology","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109903"}}